相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pharmacological targeting of RAS: Recent success with direct inhibitors
John P. O'Bryan
PHARMACOLOGICAL RESEARCH (2019)
Targeted Sequencing of Malignant Supratentorial Pediatric Brain Tumors Demonstrates a High Frequency of Clinically Relevant Mutations
Bonnie L. Cole et al.
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY (2018)
Evidence for Genetic Risk Contributing to Long-Term Adverse Treatment Effects in Childhood Cancer Survivors
Maria Monica Gramatges et al.
ANNUAL REVIEW OF MEDICINE, VOL 69 (2018)
MAX to MYCN intracellular ratio drives the aggressive phenotype and clinical outcome of high risk neuroblastoma
Francesca Ferrucci et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2018)
Histone deacetylases 1 and 2 regulate the transcriptional programs of nephron progenitors and renal vesicles
Hongbing Liu et al.
DEVELOPMENT (2018)
Identification of a novel CTR9 germline mutation in a family with Wilms tumor
Antonio G. Martins et al.
EUROPEAN JOURNAL OF MEDICAL GENETICS (2018)
Relapse of Wilms' tumour and detection methods: a retrospective analysis of the 2001 Renal Tumour Study Group-International Society of Paediatric Oncology Wilms' tumour protocol database
Jesper Brok et al.
LANCET ONCOLOGY (2018)
Four evolutionary trajectories underlie genetic intratumoral variation in childhood cancer
Jenny Karlsson et al.
NATURE GENETICS (2018)
Germline mutations and somatic inactivation of TRIM28 in Wilms tumour
Benjamin J. Halliday et al.
PLOS GENETICS (2018)
Geometry of Gene Expression Space of Wilms' Tumors From Human Patients
Ariel Trink et al.
NEOPLASIA (2018)
Prevalence of Germline Mutations in Cancer Susceptibility Genes in Patients With Advanced Renal Cell Carcinoma
Maria I. Carlo et al.
JAMA ONCOLOGY (2018)
Pediatric Anaplastic Embryonal Rhabdomyosarcoma: Targeted Therapy Guided by Genetic Analysis and a Patient-Derived Xenograft Study
Stuart L. Cramer et al.
FRONTIERS IN ONCOLOGY (2018)
Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours
Xiaotu Ma et al.
NATURE (2018)
Single-cell transcriptomes from human kidneys reveal the cellular identity of renal tumors
Matthew D. Young et al.
SCIENCE (2018)
Somatic TP53 Mutations Are Detectable in Circulating Tumor DNA from Children with Anaplastic Wilms Tumors
Taryn D. Treger et al.
TRANSLATIONAL ONCOLOGY (2018)
Childhood cancer incidence and survival in Japan and England: A population-based study (1993-2010)
Kayo Nakata et al.
CANCER SCIENCE (2018)
K-Ras, H-Ras, N-Ras and B-Raf mutation and expression analysis in Wilms tumors: association with tumor growth
Efterpi Dalpa et al.
MEDICAL ONCOLOGY (2017)
Review of phase I and II trials for Wilms' tumour - Can we optimise the search for novel agents?
Jesper Brok et al.
EUROPEAN JOURNAL OF CANCER (2017)
Bilateral Wilms tumour: a review of clinical and molecular features
Jocelyn Charlton et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2017)
Wilms Tumor NCAM-Expressing Cancer Stem Cells as Potential Therapeutic Target for Polymeric Nanomedicine
Ela Markovsky et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Functional KRAS mutations and a potential role for PI3K/AKT activation in Wilms tumors
Dina Polosukhina et al.
MOLECULAR ONCOLOGY (2017)
Biallelic TRIP13 mutations predispose to Wilms tumor and chromosome missegregation
Shawn Yost et al.
NATURE GENETICS (2017)
A Children's Oncology Group and TARGET initiative exploring the genetic landscape of Wilms tumor
Samantha Gadd et al.
NATURE GENETICS (2017)
Rationale for the treatment of Wilms tumour in the UMBRELLA SIOP-RTSG 2016 protocol
Marry M. van den Heuvel-Eibrink et al.
NATURE REVIEWS UROLOGY (2017)
Emerging Insights into the Roles of the Paf1 Complex in Gene Regulation
S. Branden Van Oss et al.
TRENDS IN BIOCHEMICAL SCIENCES (2017)
Evidence of In Vitro Preservation of Human Nephrogenesis at the Single-Cell Level
Naomi Pode-Shakked et al.
STEM CELL REPORTS (2017)
BARD1 Gene Polymorphisms Confer Nephroblastoma Susceptibility
Wen Fu et al.
EBIOMEDICINE (2017)
Association Between HACE1 Gene Polymorphisms and Wilms' Tumor Risk in a Chinese Population
Wei Jia et al.
CANCER INVESTIGATION (2017)
TP53 alterations in Wilms tumour represent progression events with strong intratumour heterogeneity that are closely linked but not limited to anaplasia
Jenny Wegert et al.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2017)
Clinical Outcome and Biological Predictors of Relapse After Nephrectomy Only for Very Low-risk Wilms Tumor A Report From Children's Oncology Group AREN0532
Conrad V. Fernandez et al.
ANNALS OF SURGERY (2017)
Identification of germline DICER1 mutations and loss of heterozygosity in familial Wilms tumour
Timothy Blake Palculict et al.
JOURNAL OF MEDICAL GENETICS (2016)
miR-200 promotes the mesenchymal to epithelial transition by suppressing multiple members of the Zeb2 and Snail1 transcriptional repressor complexes
R. Perdigao-Henriques et al.
ONCOGENE (2016)
Fibroblast growth factor receptor signaling in kidney and lower urinary tract development
Kenneth A. Walker et al.
PEDIATRIC NEPHROLOGY (2016)
Nephroblastomatosis or Wilms tumor in a fourth patient with a somatic PIK3CA mutation
Karen W. Gripp et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2016)
Phenotype, Cancer Risk, and Surveillance in Beckwith-Wiedemann Syndrome Depending on Molecular Genetic Subgroups
Saskia M. Maas et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2016)
Whole-exome sequencing reveals the spectrum of gene mutations and the clonal evolution patterns in paediatric acute myeloid leukaemia
Norio Shiba et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
Significance of TP53 Mutation in Wilms Tumors with Diffuse Anaplasia: A Report from the Children's Oncology Group
Ariadne H. A. G. Ooms et al.
CLINICAL CANCER RESEARCH (2016)
Biology and treatment of renal tumours in childhood
Jesper Brok et al.
EUROPEAN JOURNAL OF CANCER (2016)
Phase I Study of the Aurora A Kinase Inhibitor Alisertib in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma: A NANT (New Approaches to Neuroblastoma Therapy) Trial
Steven G. DuBois et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Gain of 1q As a Prognostic Biomarker in Wilms Tumors (WTs) Treated With Preoperative Chemotherapy in the International Society of Paediatric Oncology (SIOP) WT 2001 Trial: A SIOP Renal Tumours Biology Consortium Study
Tasnim Chagtai et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Association of Chromosome 1q Gain With Inferior Survival in Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group
Eric J. Gratias et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS
Melissa C. Southey et al.
JOURNAL OF MEDICAL GENETICS (2016)
Cancer Risk in Beckwith-Wiedemann Syndrome: A Systematic Review and Meta-Analysis Outlining a Novel (Epi)Genotype Specific Histotype Targeted Screening Protocol
Alessandro Mussa et al.
JOURNAL OF PEDIATRICS (2016)
Anaplastic histology Wilms' tumors registered to the Japan Wilms' Tumor Study Group are less aggressive than that in the National Wilms' Tumor Study 5
Takaharu Oue et al.
PEDIATRIC SURGERY INTERNATIONAL (2016)
Dissecting Stages of Human Kidney Development and Tumorigenesis with Surface Markers Affords Simple Prospective Purification of Nephron Stem Cells
Naomi Pode-Shakked et al.
SCIENTIFIC REPORTS (2016)
The Many Roles of BAF (mSWI/SNF) and PBAF Complexes in Cancer
Courtney Hodges et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
Genomic imbalances pinpoint potential oncogenes and tumor suppressors in Wilms tumors
A. C. V. Krepischi et al.
MOLECULAR CYTOGENETICS (2016)
Risk of Childhood Cancer by Maternal Birthplace A Test of the Hispanic Paradox
Julia E. Heck et al.
JAMA PEDIATRICS (2016)
Collaboration of MLLT1/ENL, Polycomb and ATM for transcription and genome integrity
Ayako Ui et al.
NUCLEUS (2016)
Collaboration of MLLT1/ENL, Polycomb and ATM for transcription and genome integrity
Ayako Ui et al.
NUCLEUS (2016)
Clinical Overview of MDM2/X-Targeted Therapies
Andrew Burgess et al.
FRONTIERS IN ONCOLOGY (2016)
Clinical Management of Patients with ASXL1 Mutations and Bohring-Opitz Syndrome, Emphasizing the Need for Wilms Tumor Surveillance
Bianca Russell et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2015)
A high incidence of WT1 abnormality in bilateral Wilms tumours in Japan, and the penetrance rates in children with WT1 germline mutation
Y. Kaneko et al.
BRITISH JOURNAL OF CANCER (2015)
Recurrent DGCR8, DROSHA, and SIX Homeodomain Mutations in Favorable Histology Wilms Tumors
Amy L. Walz et al.
CANCER CELL (2015)
Mutations in the SIX1/2 Pathway and the DROSHA/DGCR8 miRNA Microprocessor Complex Underlie High-Risk Blastemal Type Wilms Tumors
Jenny Wegert et al.
CANCER CELL (2015)
The yin and yang of kidney development and Wilms' tumors
Peter Hohenstein et al.
GENES & DEVELOPMENT (2015)
Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration
Jeffrey S. Dome et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Towards an understanding of kidney diseases associated with WT1 mutations
Lihua Dong et al.
KIDNEY INTERNATIONAL (2015)
Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial
Kathy Pritchard-Jones et al.
LANCET (2015)
Mutations in the transcriptional repressor REST predispose to Wilms tumor
Shazia S. Mahamdallie et al.
NATURE GENETICS (2015)
Alisertib is active as single agent in recurrent atypical teratoid rhabdoid tumors in 4 children
Cynthia Wetmore et al.
NEURO-ONCOLOGY (2015)
MLLT1 YEATS domain mutations in clinically distinctive Favourable Histology Wilms tumours
Elizabeth J. Perlman et al.
NATURE COMMUNICATIONS (2015)
Recurrent internal tandem duplications of BCOR in clear cell sarcoma of the kidney
Angshumoy Roy et al.
NATURE COMMUNICATIONS (2015)
Intratumoral genome diversity parallels progression and predicts outcome in pediatric cancer
Linda Holmquist Mengelbier et al.
NATURE COMMUNICATIONS (2015)
Proteomic analysis of embryonic kidney development: Heterochromatin proteins as epigenetic regulators of nephrogenesis
Gry H. Dihazi et al.
SCIENTIFIC REPORTS (2015)
Comparative methylome analysis identifies new tumour subtypes and biomarkers for transformation of nephrogenic rests into Wilms tumour
Jocelyn Charlton et al.
GENOME MEDICINE (2015)
Stratification of Wilms tumor by genetic and epigenetic analysis
Richard H. Scott et al.
Oncotarget (2015)
Drugging MYCN through an Allosteric Transition in Aurora Kinase A
William Clay Gustafson et al.
CANCER CELL (2014)
Lin28 sustains early renal progenitors and induces Wilms tumor
Achia Urbach et al.
GENES & DEVELOPMENT (2014)
The N-myc Oncogene: Maximizing its Targets, Regulation, and Therapeutic Potential
Himisha Beltran
MOLECULAR CANCER RESEARCH (2014)
Clarifying the Impact of Polycomb Complex Component Disruption in Human Cancers
Yukiya Yamamoto et al.
MOLECULAR CANCER RESEARCH (2014)
Drugging the undruggable RAS: Mission Possible?
Adrienne D. Cox et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Malformations, Genetic Abnormalities, and Wilms Tumor
S. Dumoucel et al.
PEDIATRIC BLOOD & CANCER (2014)
TP53 Mutational Status Is a Potential Marker for Risk Stratification in Wilms Tumour with Diffuse Anaplasia
Mariana Maschietto et al.
PLOS ONE (2014)
Germline mutations in the PAF1 complex gene CTR9 predispose to Wilms tumour
Sandra Hanks et al.
NATURE COMMUNICATIONS (2014)
Somatic mutations in DROSHA and DICER1 impair microRNA biogenesis through distinct mechanisms in Wilms tumours
Dinesh Rakheja et al.
NATURE COMMUNICATIONS (2014)
Recurrent somatic mutation in DROSHA induces microRNA profile changes in Wilms tumour
Giovana T. Torrezan et al.
NATURE COMMUNICATIONS (2014)
The IGF signalling pathway in Wilms tumours - A report from the ENCCA Renal Tumours Biology-driven drug development workshop
Mariana Maschietto et al.
ONCOTARGET (2014)
Wilms' Tumor Blastemal Stem Cells Dedifferentiate to Propagate the Tumor Bulk
Rachel Shukrun et al.
STEM CELL REPORTS (2014)
Mi-2/NuRD is required in renal progenitor cells during embryonic kidney development
D. R. Denner et al.
DEVELOPMENTAL BIOLOGY (2013)
The isolation and characterization of renal cancer initiating cells from human Wilms' tumour xenografts unveils new therapeutic targets
Naomi Pode-Shakked et al.
EMBO MOLECULAR MEDICINE (2013)
An international strategy to determine the role of high dose therapy in recurrent Wilms' tumour
Tam C. Ha et al.
EUROPEAN JOURNAL OF CANCER (2013)
Gain of 1q Is a Marker of Poor Prognosis in Wilms' Tumors
H. Segers et al.
GENES CHROMOSOMES & CANCER (2013)
Epigenetic and genetic alterations of the imprinting disorder Beckwith-Wiedemann syndrome and related disorders
Hidenobu Soejima et al.
JOURNAL OF HUMAN GENETICS (2013)
Comprehensivemolecular characterization of clear cell renal cell carcinoma
Chad J. Creighton et al.
NATURE (2013)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
Initial Testing (Stage 1) of the Antibody-Maytansinoid Conjugate, IMGN901 (Lorvotuzumab Mertansine), by the Pediatric Preclinical Testing Program
Andrew C. Wood et al.
PEDIATRIC BLOOD & CANCER (2013)
Six2 and Wnt Regulate Self-Renewal and Commitment of Nephron Progenitors through Shared Gene Regulatory Networks
Joo-Seop Park et al.
DEVELOPMENTAL CELL (2012)
A genome-wide association study identifies susceptibility loci for Wilms tumor
Clare Turnbull et al.
NATURE GENETICS (2012)
Germline mutations in DIS3L2 cause the Perlman syndrome of overgrowth and Wilms tumor susceptibility
Dewi Astuti et al.
NATURE GENETICS (2012)
Clinically Relevant Subsets Identified by Gene Expression Patterns Support a Revised Ontogenic Model of Wilms Tumor: A Children's Oncology Group Study
Samantha Gadd et al.
NEOPLASIA (2012)
β-Catenin and K-RAS Synergize to Form Primitive Renal Epithelial Tumors with Features of Epithelial Wilms' Tumors
Peter E. Clark et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Nonsense Mutation and Inactivation of SMARCA4 (BRG1) in an Atypical Teratoid/Rhabdoid Tumor Showing Retained SMARCB1 (INI1) Expression
Martin Hasselblatt et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
MAP3K4/CBP-Regulated H2B Acetylation Controls Epithelial-Mesenchymal Transition in Trophoblast Stem Cells
Amy N. Abell et al.
CELL STEM CELL (2011)
A Wt1-Controlled Chromatin Switching Mechanism Underpins Tissue-Specific Wnt4 Activation and Repression
Abdelkader Essafi et al.
DEVELOPMENTAL CELL (2011)
Clinical utility gene card for: WAGR syndrome
Carol Clericuzio et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2011)
Molecular Profiling Reveals Frequent Gain of MYCN and Anaplasia-Specific Loss of 4q and 14q in Wilms Tumor
Richard D. Williams et al.
GENES CHROMOSOMES & CANCER (2011)
Tumor Suppressor Menin Represses Paired Box Gene 2 Expression via Wilms Tumor Suppressor Protein-Polycomb Group Complex
Bin Xu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Wt1 ablation and Igf2 upregulation in mice result in Wilms tumors with elevated ERK1/2 phosphorylation
Qianghua Hu et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
WT1 Mutation and 11P15 Loss of Heterozygosity Predict Relapse in Very Low-Risk Wilms Tumors Treated With Surgery Alone: A Children's Oncology Group Study
Elizabeth J. Perlman et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Dicer regulates the development of nephrogenic and ureteric compartments in the mammalian kidney
Vidya K. Nagalakshmi et al.
KIDNEY INTERNATIONAL (2011)
Update on Relapses in Unilateral Nephroblastoma Registered in 3 Consecutive SIOP/GPOH Studies - A Report from the GPOH-Nephroblastoma Study Group
R. Furtwaengler et al.
KLINISCHE PADIATRIE (2011)
The Genetic Landscape of the Childhood Cancer Medulloblastoma
D. Williams Parsons et al.
SCIENCE (2011)
Genomic characterization of Wilms' tumor suppressor 1 targets in nephron progenitor cells during kidney development
Sunny Hartwig et al.
DEVELOPMENT (2010)
Treatment of relapsed Wilms tumors: lessons learned
Filippo Spreafico et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2009)
WTX Inactivation Is a Frequent, but Late Event in Wilms Tumors Without Apparent Clinical Impact
Jenny Wegert et al.
GENES CHROMOSOMES & CANCER (2009)
High frequency of tumours in Mulibrey nanism
Niklas Karlberg et al.
JOURNAL OF PATHOLOGY (2009)
Rest and the restless: in stem cells and beyond
Vidya Gopalakrishnan
FUTURE NEUROLOGY (2009)
Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study group
Marcio Malogolowkin et al.
PEDIATRIC BLOOD & CANCER (2008)
Accumulation of malignant renal stem cells is associated with epigenetic changes in normal renal progenitor genes
Sally Metsuyanim et al.
STEM CELLS (2008)
A novel corepressor, BCoR-L1, represses transcription through an interaction with CtBP
Julia K. Pagan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D: A report from the national Wilms tumor study group
Daniel M. Green et al.
PEDIATRIC BLOOD & CANCER (2007)
An X chromosome gene, WTX, is commonly inactivated in Wilms tumor
Miguel N. Rivera et al.
SCIENCE (2007)
Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer
Sarah Reid et al.
NATURE GENETICS (2007)
Six2 is required for suppression of nephrogenesis and progenitor renewal in the developing kidney
Michelle Self et al.
EMBO JOURNAL (2006)
Annual report to the nation on the status of cancer, 1975-2003, featuring cancer among US Hispanic/Latino populations
Holly L. Howe et al.
CANCER (2006)
Genetic and epigenetic alterations on the short arm of chromosome 11 are involved in a majority of sporadic Wilms' tumours
Y. Satoh et al.
BRITISH JOURNAL OF CANCER (2006)
Constitutional UPD for chromosome 11p15 in individuals with isolated hemihyperplasia is associated with high tumor risk and occurs following assisted reproductive technologies
Cheryl Shuman et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2006)
Multiple imprinted and sternness genes provide a link between normal and tumor progenitor cells of the developing human kidney
B Dekel et al.
CANCER RESEARCH (2006)
Treatment of anaplastic histology Wilms' tumor: Results from the fifth National Wilms' Tumor Study
Jeffrey S. Dome et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour
R. H. Scott et al.
JOURNAL OF MEDICAL GENETICS (2006)
Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: A report from the National Wilms Tumor Study Group
PE Grundy et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Molecular subtypes and phenotypic expression of Beckwith-Wiedemann syndrome
WN Cooper et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2005)
Disruption of cooperation between Ras and MycN in human neuroblastoma cells promotes growth arrest
S Yaari et al.
CLINICAL CANCER RESEARCH (2005)
High incidence of malformation syndromes in a series of 1,073 children with cancer
JHM Merks et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2005)
Wilms' tumour: Connecting tumorigenesis and organ development in the kidney
MN Rivera et al.
NATURE REVIEWS CANCER (2005)
Epigenetic differences between Wilms' tumours in white and east-Asian children
R Fukuzawa et al.
LANCET (2004)
Familial Wilms tumor
EC Ruteshouser et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS (2004)
SIX1 mutations cause branchio-oto-renal syndrome by disruption of EYA1-SIX1-DNA complexes
RG Ruf et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Characteristics and outcomes of children with the Wilms Tumor-Aniridia syndrome: A report from the National Wilms Tumor Study Group
NE Breslow et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Six1 is required for the early organogenesis of mammalian kidney
PX Xu et al.
DEVELOPMENT (2003)
Coordinating early kidney development: Lessons from gene targeting
S Vainio et al.
NATURE REVIEWS GENETICS (2002)
Axin-mediated CKI phosphorylation of β-catenin at Ser 45:: a molecular switch for the Wnt pathway
S Amit et al.
GENES & DEVELOPMENT (2002)
Treatment with nephrectomy only for small, stage I/favorable histology Wilms' tumor: A report from the National Wilms' Tumor Study Group
DM Green et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
分享论文
